SLC5A2 and myopathy: This case illustrates a rare but clinically significant triad of simvastatin-induced myopathy, thiazide-induced hypokalemia, and possible SGLT2 inhibitor potentiation through osmotic diuresis and intravascular volume depletion, which can impair muscle perfusion and augment statin-induced severe rhabdomyolysis.